Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 67.2B | 67.6B | 69.0B | 67.7B |
| Cost of revenue | 50.0B | 51.0B | 52.5B | 51.6B |
| Gross profit | 17.2B | 16.6B | 16.5B | 16.1B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 365.6M | 352.2M | 343.3M | 337.0M |
| Operating income | 16.9B | 16.3B | 16.1B | 15.7B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 16.8B | 16.3B | 16.1B | 15.8B |
| Tax provision | 0 | 0 | 0 | 0 |
| Net income | 16.8B | 16.3B | 16.1B | 15.8B |
| Basic EPS | — | 1.3 | 1.2 | 1.2 |
| Diluted EPS | — | 1.3 | 1.2 | 1.2 |
| Basic average shares | — | 13.0B | 13.1B | 13.0B |
| Diluted average shares | — | 13.0B | 13.1B | 13.0B |
| EBITDA | 16.9B | 16.3B | 16.1B | 15.7B |
| Net income from continuing op. | 16.8B | 16.3B | 16.1B | 15.8B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 0 | 0 | 0 | 0 |